COMPARATIVE STUDY OF SERUM LEPTIN, LIPID PROFILE AND FBG IN OVERWEIGHT, AND OBESE SUBJECTS IN NNEWI SOUTH-EAST NIGERIA
Department of Chemical Pathology, Faculty of Basic Clinical Sciences, College of Health Sciences, Nnamdi Azikiwe University, Awka, Anambra State Nigeria
Department of Chemical Pathology, Faculty of Basic Clinical Sciences, College of Health Sciences, Nnamdi Azikiwe University, Awka, Anambra State Nigeria
Department of Chemical Pathology, Faculty of Basic Clinical Sciences, College of Health Sciences, Nnamdi Azikiwe University, Awka, Anambra State Nigeria
Department of Chemical Pathology, Faculty of Basic Clinical Sciences, College of Health Sciences, Nnamdi Azikiwe University, Awka, Anambra State Nigeria
Department of Chemical Pathology, Faculty of Basic Clinical Sciences, College of Health Sciences, Nnamdi Azikiwe University, Awka, Anambra State Nigeria
Department of Chemical Pathology, Faculty of Basic Clinical Sciences, College of Health Sciences, Nnamdi Azikiwe University, Awka, Anambra State Nigeria
Department of Chemical Pathology National Hospital, Abuja Nigeria
DOI:
https://doi.org/10.56943/jsh.v3i1.471Introduction. Obesity is caused by an imbalance between food intake and energy expenditure, leading to excessive fat accumulation in organs. Leptin, an adipokine, reflects adiposity and its levels increase with weight gain and decrease with weight loss. The purpose of this study was to compare of serum leptin, lipid profile and FBG in overweight. Methods. This is a cross-sectional study. A total of 90 healthy obese, overweight, and normal-weight participants who met the inclusion criteria were enrolled in the study. They were grouped using their body mass index of 18.5 to 24.9 kg/m2 (normal weight), 25 to 29.9 kg/m2 (overweight) and ≥30 kg/m2 (obese). The measured parameters were analyzed using standard methods. Results and Analysis. There was an increased difference in the mean level of Leptin (ug/l) of the obese participants compared to normal weight participants (0.63±0.29 vs 0.25±0.26, 0.001) and overweight when compared to normal weight (0.51±0.27 vs 0.25±0.26, 0.003). A significant positive correlation was observed when the leptin and BMI of obese subjects were compared. Mean fasting very low-density lipoprotein (VLDL) and triglyceride (TG) (mmol/l), were significantly higher (p<0.05) in overweight compared to normal weight participants (0.76±0.31 vs. 0.47±0.22) and (1.72±0.60 vs. 1.09±0.51) and obese participants (0.82±0.23 vs. 0.47±0.22) and (1.85±0.59 vs. 1.09±0.51) when compared to normal weight subjects respectively. Discussions. The level of leptin was increased in the overweight and obese groups when compared to the control groups and correlates positively with the BMI of the overweight and obese groups.
Keywords: FBG Leptin Lipid Profile Obesity
Jeanrenaud FR, Jeanrenaud B. Obesity, Leptin and the Brain. New England Journal of Medicine 1996. 334:324–5.
Conde J, Scotece M, Gómez R, López V, Gómez-Reino JJ, Lago F, Gualillo O. "Adipokines: biofactors from white adipose tissue. A complex hub among inflammation, metabolism, and immunity". Biofactors. 2011. 37 (6): 413–20.
Brennan AM, Mantzoros CS. Drug Insight: the role of leptin in human physiology and pathophysiology-emerging clinical applications. Natural Clinical Practical Endocrinology and Metabolism. 2006. 2: 318-327.
Bravo PE, Morse S, Borne DM, Aguilar EA, Reisin E. Leptin and hypertension in obesity. Vascular Health Risk Management 2006. 2: 163-169.
Hafizuallah AM. Leptin: fights against obesity. Pakistani Journal of Physiology 2006. 2: 1-7.
Rodriguez E.M, Blazquez J.L, Guerra, M. The design of barriers in the hypothalamus allows the median eminence and the arcuate nucleus to enjoy private milieus: The former opens to the portal blood and the latter to the cerebrospinal fluid. Peptides, 2010. 31:757–776.
Moraes J.C, Coope, A, Morari J, Cintra D.E, Roman E.A, Pauli J.R, Romanatto T, Carvalheira J.B, Oliveira A.L, Saad M.J. et al. High-fat diet induces apoptosis of hypothalamic neurons. PLoS ONE, 2009. 4:e504.
Kim D.W, Glendining K.A, Grattan D.R, Jasoni C.L. Maternal Obesity in the Mouse Compromises the Blood-Brain Barrier in the Arcuate Nucleus of Offspring. Endocrinology, 2016. 157: 2229–2242.
Rifai N, Warnick GR. Lipids Lipoproteins, Apolipoproteins and other Cardiovascular Risk Factors. In: Burtis CA, Ashwood ER, Bruns DE. Tietz Text Book of Clinical Chemistry, 4th edition vol 3. ELsevier Saunders, 2006. 26:903-981.
Young DS, Bermes EW. Preanalytical variables and biological variation. In: Burtis CA, Ashwood ER, Bruns DE. Tietz Text Book of Clinical Chemistry, 4th edition vol 2. Hsevier Saunders, 2006. 17:449-473.
Allen CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total Serum Cholesterol. Clinical chemistry, 1974. 20:470-475.
Trinder P (1969). Determination of Glucose in Blood Using Glucose Oxidase with an Alternative Oxygen Acceptor. Annals of clinical biochemistry. 6-24
Friedwald WT, Levy RI, Fredrickson DS (1972). Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clinical Chemistry. 18 (6):499-502.
Sone M, Osamura RY. (2001). Leptin and the pituitary. Pituitary. 4:15-23.
Farr OM, Gavriell A, Mantzoros CS, (2015). Leptin application in 2015; what have we learned about leptin and obesity?. Current opinion in Endocrinology of diabetes and obesity. 22:353-359.
Mohamed AK, Hassan AJ (2017). Asses the relationship between leptin levels with classes of obesity in adult of Babylon Iraq. Mesopotamia environmental journal. 130-135.
Park HK, Ahima RS (2015). Physiology of leptin: energy homeostasis, neuroendocrine function and metabolism. Clinical and experimental journal. 64:24-34.
Crujeiras AB, et al (2015). Casanueva, leptin resistance in obesity: epigenetic landscape, life science. 140:57-63.
Riccioni G, et al. (2004). Interaction connecting leptin, obesity-insulin dependent diabetes mellitus. European journal of inflammation. 2(1):17-20.
Herrick JE, Panza GS, Gollie JM (2016). Leptin, leptin soluble receptor, and the free leptin index following a diet and physical activity lifestyle intervention in obese males and females. Journal of obesity. 83(7):58-28.
Gupta M, Mukherjee R. (2018) study on the comparative study of serum leptin and lipid profile among non-diabetic obese subjects and type 2 diabetes patients due to obesity. Biochemistry Indian Journal. 12(3):132.
Haddad NIA. Nori E and Hamza SA (2017). Serum visfatin and chemerin levels in Iraqi diabetics and obese individuals. RJPBCS. 8(6):356-64.
Zavorini I. Dall’aglio E, Alpi O, et al (1985). Evidence for an independent relationship between plasma insulin and concentration of high density lipoprotein cholesterol and triglyceride. Atherosclerosis. 55:259-66.
Howard BV, Ruotolo G, Robbins DC (2003). Obesity and dyslipidemia. Endocrinology of Metabolic Clinic North America. 1(1):27-32.
National Cholesterol Education Program (Ncep) Expert Panel On Detection, E. (2002). "Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report". Circulation. 106 (25): 3143–3421.
Prema GS, Anitha P, Padmini O. (2016). Relation between body mass index (BMI) and fasting blood sugar (FBS). International journal of contemporary medical research. 3(1):91-94.
Agrawal N, Mukesh KA Tannu K, Sunil K. (2017). Correlation between body mass index and blood glucose levels in Jharkhand population. International journal of contemporary medical research. 4(8):1633-1636.
